Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide Nasal Spray Onset of Action in SAR
NCT00384475Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Oct 2006
- Primary completion
- Jan 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in seasonal allergic rhinitis (SAR) comparing Ciclesonide Nasal Spray with Placebo Nasal Spray (2 arms). Primary endpoint: Onset of action. Started Oct 2006; status: completed.
02
Drugs
ciclesonide
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00384475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00384475.